Andres Gutiérrez

Andres Gutiérrez

Chief Tech/Sci/R&D Officer at ADVAXIS, INC.
65 year
Health Technology
Consumer Services
Health Services

Profile

Andres A. Gutiérrez is currently Chief Medical Officer at Old Ayala, Inc. since 2023 and Chief Medical Officer at Biosight Therapeutics, Inc. since 2018.
Former positions include Chief Medical Officer & Executive Vice President at Ayala Pharmaceuticals, Inc. from 2018 to 2024; Chief Medical Officer at Instil Bio, Inc. in 2025; Chief Medical Officer at Oncolytics Biotech, Inc. from 2016 to 2018; Chief Medical Officer at Sellas Life Sciences Group Ltd. from 2015 to 2016; Medical Director-Early Development Immuno-Oncology at Bristol Myers Squibb Co. from 2012 to 2015; Chief Medical Officer & Executive Vice President at Advaxis, Inc.; Medical Director at BioMarin Pharmaceutical, Inc., Sonoma Pharmaceuticals, Inc., Sunesis Pharmaceuticals, Inc., and Proteolix, Inc.; Director-Gene & Cell Therapy Unit at Instituto Nacional de Salud Pública de México and Instituto Nacional de Ciencias Medicas y Nutricion.
Education includes a doctorate from Universidad Nacional Autónoma de México.

Andres Gutiérrez active positions

CompaniesPositionStart
ADVAXIS, INC. Chief Tech/Sci/R&D Officer 2023-01-18

Former positions of Andres Gutiérrez

CompaniesPositionEnd
INSTIL BIO, INC. Chief Tech/Sci/R&D Officer 2025-06-01
AYALA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2024-03-24
ONCOLYTICS BIOTECH INC. Chief Tech/Sci/R&D Officer 2018-04-22
Chief Tech/Sci/R&D Officer 2016-08-31
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 2015-10-31
See the detail of Andres Gutiérrez's experience

Training of Andres Gutiérrez

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

30

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Instituto Nacional de Salud Pública de México

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Andres Gutiérrez